| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |